Safety And Efficacy Of 4 Years Of Deferasirox Treatment For Sickle Cell Disease Patients

Author: Vlachaki Efthymia  

Publisher: Informa Healthcare

ISSN: 0363-0269

Source: Hemoglobin, Vol.37, Iss.1, 2013-02, pp. : 94-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract